Suppr超能文献

腹主动脉瘤开放或血管内修复的长期结果。

Long-term outcome of open or endovascular repair of abdominal aortic aneurysm.

机构信息

From the Department of Surgery, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.

出版信息

N Engl J Med. 2010 May 20;362(20):1881-9. doi: 10.1056/NEJMoa0909499.

Abstract

BACKGROUND

For patients with large abdominal aortic aneurysms, randomized trials have shown an initial overall survival benefit for elective endovascular repair over conventional open repair. This survival difference, however, was no longer significant in the second year after the procedure. Information regarding the comparative outcome more than 2 years after surgery is important for clinical decision making.

METHODS

We conducted a long-term, multicenter, randomized, controlled trial comparing open repair with endovascular repair in 351 patients with an abdominal aortic aneurysm of at least 5 cm in diameter who were considered suitable candidates for both techniques. The primary outcomes were rates of death from any cause and reintervention. Survival was calculated with the use of Kaplan-Meier methods on an intention-to-treat basis.

RESULTS

We randomly assigned 178 patients to undergo open repair and 173 to undergo endovascular repair. Six years after randomization, the cumulative survival rates were 69.9% for open repair and 68.9% for endovascular repair (difference, 1.0 percentage point; 95% confidence interval [CI], -8.8 to 10.8; P=0.97). The cumulative rates of freedom from secondary interventions were 81.9% for open repair and 70.4% for endovascular repair (difference, 11.5 percentage points; 95% CI, 2.0 to 21.0; P=0.03).

CONCLUSIONS

Six years after randomization, endovascular and open repair of abdominal aortic aneurysm resulted in similar rates of survival. The rate of secondary interventions was significantly higher for endovascular repair. (ClinicalTrials.gov number, NCT00421330.)

摘要

背景

对于患有大型腹主动脉瘤的患者,随机试验表明,与传统的开放性修复相比,择期血管内修复具有初始的总体生存优势。然而,这种生存差异在手术后的第二年就不再显著。手术 2 年以上的比较结果信息对临床决策很重要。

方法

我们进行了一项长期、多中心、随机、对照试验,比较了 351 名腹主动脉瘤直径至少 5 厘米且适合两种技术的患者的开放性修复与血管内修复。主要结果是任何原因导致的死亡率和再干预率。使用 Kaplan-Meier 方法基于意向治疗进行生存计算。

结果

我们随机分配 178 名患者进行开放性修复,173 名患者进行血管内修复。随机分组 6 年后,开放性修复的累积生存率为 69.9%,血管内修复为 68.9%(差异为 1.0 个百分点;95%置信区间[CI],-8.8 至 10.8;P=0.97)。开放性修复的无二次干预自由率为 81.9%,血管内修复为 70.4%(差异为 11.5 个百分点;95%CI,2.0 至 21.0;P=0.03)。

结论

随机分组 6 年后,血管内和开放性修复腹主动脉瘤的生存率相似。血管内修复的二次干预率明显更高。(临床试验.gov 编号,NCT00421330。)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验